iWiMS Global Scientific Meetings


NMOSD/MOGAD scientific group: Patient information webinar – December 14/15

Our webinar aimed to inform patients can be accessed on 14/15 December at this link

MS COVID-19 Meeting – go to this link for updates about dates and times


Global Epidemiology Conference – November 9/10

MS COVID-19 Meeting – July 15/16 2020

The preliminary program will include: Jan Hillert (Sweden): anti-CD20 tre

The iWiMS July 15 2020 COVID-19 meeting was hosted by Fabienne Brillot. We heard an update from Celine Louapre (French Registry), specifically talking about COVID-19 in people with NMOSD. Amber Salter (COViMS Registry US) gave an update on the US experience. Both speakers spoke to comorbidities, and treamtent impacts.
The formal talks were followed by a discussion of DMT considerations given the data that has been presented and published over the last months. Together with a discussion of possible impact of steroid exposure on COVID outcomes. We again thank all of our speakers for their time and generosity in sharing their data with our community.

MS COVID-19 Meeting – July 1/2 2020

In the July 1 2020 iWiMS COVID-19 meeting Dr Jeanne Billioux (NIH, USA) gave an update on COVID-19 treatments, clinical trials, and vaccines in development. We thank her for this excellent summary of the current state of play.

MS COVID-19 Meeting – June 17/18 2020

In the June 17 iWiMS COVID-19 update Dr Ruth Dobson (QMUL, UK) asks the question: What role does VitaminD play in COVID-19 outcomes? Dr Kate Fitzgerald (JHU, USA) presents data from a collaborative effort with Cemcat looking at predictors of COVID-19 infection in people with MS. Louise Rath, clinical nurse consultant at Aflred Health (AU) describes their experiences of rapid infusion regimens for natalizumab and ocrelizumab in the time of COVID-19.

Also available in the iWiMS Virtual Conference Podcast.

MS COVID-19 Meeting – June 3/4 2020

After a fortnight break, Anne-Katrin Pröbstel hosts latest COVID-19 meeting. We welcomed Sandra Amor (The Netherlands) who gave an update on innate immune evasion by the SARS-CoV-2 virus. We also had updates from three registries including: Celine Louapre (FR) – French MS COVID-19 Regristry, Afagh Garjani (UK) – UK MS Register, Amber Salter (US) – COViMS Registry. Again we thank all of our speakers for sharing their expertise and experience.

MS COVID-19 Meeting – May 20/21 2020

Our May 20/21 meeting was hosted by Emmanuelle Waubant. We welcomed Gavin Giovanonni (UK) discussing anti-CD20 therapies and vaccine readiness. For Gavin’s up-to-date patient information go to http://www.ms-selfie.org. Jan Hillert (SE) gave an update on the Swedish Registry data. There is a predonderance of patients in Rituximab in the Swedish Registry who have tested positive for COVID-19, but this could just be due to ascertainment bias. Georgina Arrambide (SP, CEMCAT) spoke about neurological complications of COVID-19, and mechanisms of involvement. Seth Levin (US, Columbia University NYC) spoke about the MS ReCOV study. For people in the US who wish to participate in the MS ReCOV study, links can be found here or here

MS COVID-19 Meeting – May 13/14 2020

Our May 13/14 meeting was hosted by Fabienne Brillot. We welcomed David Baker (UK) who spoke about the biology of COVID-19 in relation to MS therapies. Dr Baker has co-authored a paper found here, describing what he discussed today. Nick Rijke representing MSIF, updated us regarding the MS Data Alliance MS COVID-19 Registry effort. Jan Hillert (SE) gave an update on MS COVID-19 cases from the Swedish Register.  Celine Louapre (FR) with updates from the French Registry including both MS and NMOSD patients. Amber Salter (COViMS Registry). Lauren Krupp (USA) presents the latest data from New York.

MS COVID-19 Meeting – May 6/7 2020

Our May 6/7 meeting was hosted by Dr. Georgina Arrambide. We welcomed Heinz Wiendl (DE) who spoke about MS, COVID-19 and B-cell depleting therapies. Anneke Van der Walt (AU) presented data on Australian and New Zealand MS COVID-19 patients; and presented the MSBase Registry effort to capture MS COVID-19 patient data. Maria Pia Sormani (IT) presented the latest data from the MuSC-19 Registry. Finally Cerlia Oreja-Guevara gave an update on the Spanish MS COVID-19 registry data.

MS COVID-19 Meeting – April 29/30 2020

Our April 29/30 meeting was hosted by Dr. Anne-Katrin Pröbstel. We welcomed Anne Cross, Jeffrey Cohen, and Kate Fitzgerald (USA), Farinaz Safavi (Iran ), and Nikos Evangelou (UK). Michael Wilson also spoke on serology tests of patients with COVID19. Scott Zamvil spoke on immune responses to COVID19 under DMTs.

MS COVID-19 Meeting – April 22/23 2020

Our April 22/23 meeting was hosted by Marwa Kasey. We welcomed Jeffrey Bennett who explained the immunological aspects of COVID-19 and issues related to MS therapies. Data from China presented by Fu-Dong Shi (China). Lauren Krupp presents updates from New York, and reassuring data on pediatric COVID-19 MS cases. Further updates from Celine Louapre (France), Rick Rijke (MISF), Ana Zabalza (Barcelona), Amber Salter (USA), Celia Oreja-Guevara (Madrid).

MS COVID-19 Meeting – April 15/16 2020

Our April 15/16 meeting was hosted by Emmanuelle Waubant. Speakers included Jan Hillert (SE), Celine Louapre (FR), Magd Zakaria (EG), Marco Aurélio Lana Peixoto (BR), Amber Salter (US), Ellen Mowry (US), Jeff Cohen (US), Maria Trojano (IT), Nick Rijke (MSIF), Mar Tintore (ES), Kerstin Hellwig (DE), Lauren Krupp (US), Miriam Mattoscio (UK), Aksel Siva (TR).
Globally, we estimate that there are ~600 people with MS who have been infected with COVID-19. Discussions included progress of MS COVID-19 Registries, sharing of preliminary MS COVID-19 registry data, information on pediatric cases, DMT use strategies in the context of COVID-19 particularly cladribine.

MS COVID-19 Meeting – April 8/9 2020

On 8 April Hosted by Anne-Katrin Proebstel (CH), Bruce Bebo (US), Jeff Cohen (US), Magd Zakaria (EG), Mar Tintore (ES), Celine Louapre (FR) Jan Hillert (Sweden), Richard Nicholas (UK), Kerstin Hellwig (DE), Maria Trojano (IT), Maria Pia Sormani (IT), Liesbet Peeters (MS Global Data Sharing Initiative), and Ellen Mowry (US) shared with us Registry updates and further COVID-19 case information.

MS COVID-19 Meeting – April 1/April 2 2020

Recording of the 2nd MS and COVID-19 discussion hosted by iWiMS.
Discussions included introduction of various global registry efforts being put together to capture treatment and outcomes data on people with MS who have tested positive for COVID-19.

Clinical Neurology conference – Feb 27/ Feb 28 2020


A/Prof Charo Blasco Quílez, Hospital Universitario Puerta de Hierro, Madrid, Spain. “Concurrence of a brain tumor and MS: A challenge for treatment. “

Prof Ayse Altintas, KOC University, Istanbul, Turkey. “ A multicentre international study to evaluate different aspects of the relationship between MS and pregnancy.”

Neuro-ophthalmology conference – Feb 10/ Feb 11 2020

Dr. Frederike Cosima Oertel, University of California San Francisco, USA
Title: Optical coherence tomography in NMOSD: Results from the CROCTINO cohort
Dr. Sara Collorone, University College London, London, UK
Title: Visual Function and Brief Cognitive Assessment for MS (BICAMS) in Optic Neuritis–Clinically Isolated Syndrome Patients

Pediatric Demyelinating Disease Conference – Feb 6/7 2020


Ermelinda De Meo, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Italy. Neuroimaging in the CNS white matter.
Leslie Benson, Boston Children’s, Harvard Medical School, Boston, Massachusetts. HLH in children.

Neuroimaging Conference – Jan 28/Jan 29, 2020


Frederique Boonstra, Monash University, Melbourne, Australia
Tremor in multiple sclerosis with a neuroimaging perspective
Myrte Strik, University of Melbourne, Melbourne, Australia & VU University, Amsterdam, Netherlands
Investigation of upper and lower limb disability progression in multiple sclerosis with longitudinal functional network dynamics
Antje Bischof, UCSF, San Francisco, CA, USA
Legacy brain scans reveal rapid cord atrophy rates before conversion to secondary progressive multiple sclerosis

Global Epidemiology Conference – 27/28 January 2020


Dr Vilija Jokubaitis, PhD., Senior Research Fellow, Department of Neuroscience, Monash University, Australia and Honorary Senior Research Fellow Alfred Hospital, Melbourne, Australia
Title: Pregnancy, CIS and MS in the modern day
Dr Sarah Morrow, M.D., M.S.C.E., Associate Professor, Department of Clinical Neurological Sciences, Western University, London, Ontario, Canada
Title: Treating acute optic neuritis with bioequivalent doses of oral or intravenous steroids
Dr Jo Lane, Ph.D., Research Fellow, Research School of Public Health, Australian National University, Canberra, Australia
Title: My first year in MS research: reflections and the next steps”

NMOSD and MOG-Ab associated disorders – 11/12 December 2019


Dr Romina Mariano, MBBCh (Wits), DPhil Candidate and Honorary Clinical Fellow, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, The Queen’s College, University of Oxford
Title: Involvement of the spinal cord in MOG-Ab disease, NMOSD and MS
Dr Sara Samadzadeh, MD, Guest Researcher, University of Southern Denmark and Neurology Resident and post-doctoral research fellow in university hospital Düsseldorf
Title: Association of serum IgG autoantibodies specific for myelin oligodendrocyte glycoprotein (MOG-IgG) with optic neuritis

Clinical Trials Conference – 20/21 November 2019

Dr. Ellen Mowry, Johns Hopkins University
Title: Investigator-initiated clinical trials in MS: the good, the bad, and the ugly
Dr. Riley Bove, University of California San Francisco
Title: Pilot trial of hormone therapy for women with multiple sclerosis
Dr. Anneke van der Walt, Monash University
Title: Cross-over trial design: lessons learnt from a Botox-study for upper limb tremor in MS

Global Epidemiology Conference – 21 October 2019

Speaker Included:
Fardowsa Yusuf, MSc
Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome.
Tingting Zhang, MD, PhD
Effects of comorbidities on short-term functional decline among nursing home residents with multiple sclerosis.

Neuroimaging Conference – August 7, 2019

The first inaugural Neuroimaging Interest Group conference.
Our speakers:
Dr Rosa Cortese, Clinical Research Associate at UCL Institute of Neurology
The role of imaging biomarkers in different demyelinating disease phenotypes
Dr. Burcu Zeydan
Pittsburgh compound-B PET imaging in MS

Global Epidemiology Conference – July 15, 2019

Chaired by Dr Ellen Mowry, iWiMS Global Epidemiology Conference
Our speakers included:
Deanna Saylor, MD, Assistant Professor of Neurology, Johns Hopkins University/Visiting Lecturer & Consultant, University of Lusaka (Zambia). MS in sub-Saharan Africa:  Absence of Disease or Absence of Expertise?
Charity Evans, PhD, Associate Professor, College of Pharmacy and Nutrition, University of Saskatchewan. Adherence in MS: a model for other chronic diseases?
Mitzi Williams, MD, Neurologist & MS Specialist, Atlanta, GA. Addressing Diversity in MS: The African American Experience in the US

16 May 2019 – Chaired by Dr Vicki Maltby, inaugural iWiMS Global Genetics and Genomics conference.
1 April 2019 – Chaired by Dr Ellen Mowry, inaugural iWiMS Global Epidemiology Conference

Upcoming Social iWiMS Meetings